drugset / Trial / NCT00811941

Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence

NCT00811941

Phase 3 Completed 665 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is long-term safety, tolerability and efficacy of nalmefene in patients with alcohol dependence.

Timeline

Start
2009-03
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalmefene Small molecule 18.06 mg Oral

Indications